Advanced Medical Solutions Group (LSE:AMS) Median PS Value: £5.87 (As of Jun. 26, 2026) — 377% Above Median


LSE:AMS Advanced Medical Solutions Group PLC LSE:AMS
92 GF Score
Price £2.79
GF Value £3.69
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Advanced Medical Solutions Group Median PS Value?

Advanced Medical Solutions Group LSE:AMS +16.04% 92 Median PS Value is £5.87 as of Jun. 26, 2026, which is 100% below its 10-year median of 1.23. GuruFocus rates LSE:AMS with a GF Score™ of 92/100 and a GF Value™ of £3.69 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 338 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 72.78% on this metric.

This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Advanced Medical Solutions Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was £1.04. Advanced Medical Solutions Group's 10-Year median PS Ratio is 5.6442. Therefore, the Median PS Value for today is £5.87.

As of today (2026-06-26), Advanced Medical Solutions Group's share price is £2.785. Advanced Medical Solutions Group's Median PS Value is £5.87. Therefore, Advanced Medical Solutions Group's Price to Median PS Value for today is 0.47.

The historical rank and industry rank for Advanced Medical Solutions Group's Median PS Value or its related term are showing as below:

LSE:AMS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.37   Med: 1.23   Max: 1.74
Current: 0.47

During the past 13 years, the highest Price to Median PS Value of Advanced Medical Solutions Group was 1.74. The lowest was 0.37. And the median was 1.23.

LSE:AMS's Price-to-Median-PS-Value is ranked better than
72.78% of 338 companies
in the Medical Devices & Instruments industry
Industry Median: 0.71 vs LSE:AMS: 0.47

Advanced Medical Solutions Group  (LSE:AMS) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Advanced Medical Solutions Group's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=2.785/5.87
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Medical Solutions Group Median PS Value Related Terms


Advanced Medical Solutions Group Median PS Value Historical Data

* Premium members only.

The historical data trend for Advanced Medical Solutions Group's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Medical Solutions Group Median PS Value Chart

Advanced Medical Solutions Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.74 3.23 3.29 4.64 5.87

Advanced Medical Solutions Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.29 0.00 4.64 0.00 5.87

LSE:AMS vs ISRG, BDX, MDLN: Median PS Value Comparison

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group Price-to-Median-PS-Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's Price-to-Median-PS-Value falls into.


LSE:AMS
92GF Score
Advanced Medical Solutions Group PLC LSE:AMS
Median PS Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Medical Solutions Group Median PS Value Calculation

Advanced Medical Solutions Group's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=1.04*5.6442
=5.87

10-Year Median PS Ratio is 5.6442.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was £1.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Median PS Value →
What does a Median PS Value of £5.87 mean?
Advanced Medical Solutions Group (LSE:AMS) has a Median PS Value of £5.87 as of Jun. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Advanced Medical Solutions Group and its competitors. This is 377% above median its historical median of 1.23. Over the past decade, Advanced Medical Solutions Group's Median PS Value has ranged from 0.37 to 1.74. According to the industry distribution chart, Advanced Medical Solutions Group ranks #92 out of 338 companies in the Medical Devices & Instruments industry, placing it in the top 27.2%.
Is Advanced Medical Solutions Group's Median PS Value too high?
Advanced Medical Solutions Group's current Median PS Value of £5.87 is 377% above median its 10-year median of 1.23. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 1.74. Based on the distribution chart, Advanced Medical Solutions Group ranks #92 out of 338 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Median PS Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #92 out of 338 companies for Median PS Value. This puts Advanced Medical Solutions Group in the upper half of its industry. The industry median Median PS Value is 0.71. Historically, Advanced Medical Solutions Group's own Median PS Value has ranged from 0.37 to 1.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 338 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current Median PS Value is £5.87, which is 377% above median its own 10-year median of 1.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (LSE:AMS) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.69, compared to a current price of £2.79 — trading 24.5% below its estimated fair value. The current Median PS Value is £5.87, which is 377% above median its 10-year median of 1.23. Advanced Medical Solutions Group's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Advanced Medical Solutions Group (LSE:AMS), the current Median PS Value is £5.87 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Medical Solutions Group (LSE:AMS) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued. The current stock price of £2.79 is trading 24.5% below its estimated GF Value™ of £3.69. GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.

Key valuation signals for LSE:AMS:

  • Median PS Value: £5.87 (377% above median its 10-year median of 1.23)
  • GF Value™: £3.69 vs. price of £2.79 (24.5% below fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the LSE:AMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advanced Medical Solutions Group Business Description

Other Exchanges AMSl:UKAQA:Germany
Address Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
92GF Score

Get the complete analysis for LSE:AMS

Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.79
Price
£3.69
GF Value